UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Role of P-Glycoprotein in the Distribution of the HIV Protease Inhibitor Atazanavir in the Brain and Male Genital Tract

Antimicrobial Agents and Chemotherapy, 2014-03, Vol.58 (3), p.1713-1722

2014

Link zum Volltext

Verfügbarkeit prüfen

Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort

Journal of antimicrobial chemotherapy, 2010-09, Vol.65 (9), p.1889-1893

2010

Link zum Volltext

Verfügbarkeit prüfen

Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor

Therapeutic drug monitoring, 2013-02, Vol.35 (1), p.78

2013

Link zum Volltext

Verfügbarkeit prüfen

Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia

AIDS (London), 2011-02, Vol.25 (4), p.541-542

2011

Link zum Volltext

Verfügbarkeit prüfen

Saquinavir, the pioneer antiretroviral protease inhibitor

Expert opinion on drug metabolism & toxicology, 2009-10, Vol.5 (10), p.1313-1322

la Porte, Charles JL

2009

Link zum Volltext

Verfügbarkeit prüfen

Interaction Studies of Tipranavir-Ritonavir with Clarithromycin, Fluconazole, and Rifabutin in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2009-01, Vol.53 (1), p.162-173

2009

Link zum Volltext

Verfügbarkeit prüfen

Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV

PloS one, 2014, Vol.9 (1), p.e85607-e85607

2014

Link zum Volltext

Verfügbarkeit prüfen

A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults

Therapeutic drug monitoring, 2006-10, Vol.28 (5), p.650

2006

Link zum Volltext

Verfügbarkeit prüfen

Medication-based urolithiasis and atazanavir

Canadian Medical Association journal (CMAJ), 2011-08, Vol.183 (11), p.E748

2011

Link zum Volltext

Verfügbarkeit prüfen

Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult

The Annals of pharmacotherapy, 2010-01, Vol.44 (1), p.202

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of darunavir, etravirine and raltegravir in an HIV-infected patient on haemodialysis

AIDS (London), 2009-03, Vol.23 (6), p.740-742

2009

Link zum Volltext

Verfügbarkeit prüfen

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

BMC infectious diseases, 2013-06, Vol.13 (1), p.256-256, Article 256

2013

Link zum Volltext

Verfügbarkeit prüfen

Surreptitious antiretroviral use as an explanation for apparent elite HIV control

AIDS patient care and STDs, 2012-11, Vol.26 (11), p.645

2012

Link zum Volltext

Verfügbarkeit prüfen

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

AIDS (London), 2009-09, Vol.23 (15), p.2050-2054

2009

Link zum Volltext

Verfügbarkeit prüfen

P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES

HemaSphere, 2023-08, Vol.7 (S3), p.e7454106-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE‐REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL

HemaSphere, 2023-08, Vol.7 (S3), p.e1470834-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

Journal of translational medicine, 2016-03, Vol.14 (82), p.83-83, Article 83

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of Antiretroviral Therapy Duration and Intensification on Isolated Shedding of HIV-1 RNA in Semen

The Journal of infectious diseases, 2013-04, Vol.207 (8), p.1226-1234

2013

Link zum Volltext

Verfügbarkeit prüfen

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy

AIDS (London), 2003-07, Vol.17 (11), p.1700-1702

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of raltegravir in the semen of HIV-infected men

Antiviral therapy, 2014, Vol.19 (6), p.607-611

2014

Link zum Volltext

Verfügbarkeit prüfen

False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin

Therapeutic drug monitoring, 2006-04, Vol.28 (2), p.286

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications

AIDS (London), 2005-07, Vol.19 (10), p.1105-1107

2005

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory quotient in HIV pharmacology

Retrovirology, 2010-05, Vol.7 (S1), p.I9-I9, Article I9

la Porte, Charles

2010

Link zum Volltext

Verfügbarkeit prüfen

Significant interaction between activated charcoal and antiretroviral therapy leading to subtherapeutic drug concentrations, virological breakthrough and development of resistance

Antiviral therapy, 2013-01, Vol.18 (5), p.735-738

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR)

Antiviral therapy, 2004-04, Vol.9 (2), p.213-220

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(37)
Male
(27)
Infectious Diseases
(25)
Female
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Hiv Infections - Drug Therapy
(20)
Pharmacology & Pharmacy
(20)
Adult
(19)
Middle Aged
(19)
Pharmacology. Drug Treatments
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)
Pharmacokinetics
(13)
Antiviral Agents
(12)
Virology
(12)
Hiv
(11)
Human Immunodeficiency Virus
(11)
Human Viral Diseases
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of P-Glycoprotein in the Distribution of the HIV Protease Inhibitor Atazanavir in the Brain and Male Genital Tract

Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort

Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor

Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia

Saquinavir, the pioneer antiretroviral protease inhibitor

Interaction Studies of Tipranavir-Ritonavir with Clarithromycin, Fluconazole, and Rifabutin in Healthy Volunteers

Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV

A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults

Medication-based urolithiasis and atazanavir

Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult

Pharmacokinetics of darunavir, etravirine and raltegravir in an HIV-infected patient on haemodialysis

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Surreptitious antiretroviral use as an explanation for apparent elite HIV control

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES

P886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE‐REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL

A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

Impact of Antiretroviral Therapy Duration and Intensification on Isolated Shedding of HIV-1 RNA in Semen

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy

Pharmacokinetics of raltegravir in the semen of HIV-infected men

False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin

Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications

Inhibitory quotient in HIV pharmacology

Significant interaction between activated charcoal and antiretroviral therapy leading to subtherapeutic drug concentrations, virological breakthrough and development of resistance

Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR)

Suchergebnisse filtern